The Nous Research Hermes agent is moving toward business use after its maker confirmed a $90 million funding round. The company announced the financing on October 7, 2026. Publishers including TechCrunch and SiliconANGLE reported a $1.5 billion valuation, but Nous did not disclose that figure in its own note. The real test is whether developer interest can become controlled, paid enterprise use.
Key takeaways
- Nous Research says it raised $90 million and plans to build Hermes for Businesses.
- The $1.5 billion valuation is a publisher-reported figure, not a number in the company announcement.
- Nous estimates more than 24 million Hermes clones and roughly 2.5% of global AI token use; both are vendor claims without independent audit.
- Business buyers should assess permissions, data boundaries, reliability and cost before treating open-source popularity as enterprise readiness.
The Nous Research Hermes agent is an open-source assistant that can use tools and carry work across sessions. Its maker now wants to turn that developer product into something a business can govern. That is a more difficult transition than raising capital: a company must know who granted an agent access, what it did, what information left its systems and how a human can stop it.
Nous Research Hermes agent: what the funding confirms
In an October 7 note, chief executive Dillon Rolnick said Nous had raised $90 million. He named NVIDIA, Microsoft’s M12, Samsung, Robot Ventures, Union Square Ventures, Y Combinator and Menlo Ventures among investors. The note says the money will support “Hermes for Businesses,” a commercial direction for the agent. It does not give a valuation, total historical funding, a product launch date or contractual customer numbers.
TechCrunch described the financing as a Series B at a $1.5 billion valuation and said Robot Ventures led it. SiliconANGLE independently reported the same funding and valuation figures. The Next Web also reported the transaction, explicitly noting that Nous itself had not disclosed the valuation. These reports support saying the valuation was reported; they do not turn it into a company-confirmed financial disclosure.
The date matters. TechCrunch reported in July that Nous was discussing a smaller prospective round. The October announcement is a fresh, completed financing, not another story about talks. It also provides a first-party statement of the company’s intended use of proceeds. Readers should distinguish a closed raise from a product roadmap and from a commercial result.
| Item | What can be said now | Source and limit |
|---|---|---|
| New financing | $90 million | Confirmed by Nous on October 7 |
| Valuation | $1.5 billion reported | TechCrunch and SiliconANGLE; not in company note |
| Investors | NVIDIA, M12, Samsung, Robot Ventures, USV, Y Combinator and Menlo Ventures among those named | Company list does not rank all investors |
| Planned use | Hermes for Businesses | Company roadmap; deployment results undisclosed |
| Adoption | More than 24 million clones | Company estimate, not audited active users |
What Hermes does and what remains to be built
Nous Research, founded in 2023, develops open AI models and the Hermes agent. The company says it released Hermes under the permissive MIT licence in February 2026. Users can inspect the software, modify it and choose where to run it. That differs from buying access only through a closed, hosted interface, although an open licence alone does not make a deployment private or secure.
The agent is designed to use tools, work through multistep tasks and retain project context. The Next Web describes operation across desktop systems and messaging interfaces, while SiliconANGLE details model selection, routing and optional data integrations. These descriptions show capabilities and product positioning. They do not demonstrate that every workflow works without supervision, or that every deployment meets a regulated buyer’s controls.
Nous says people have cloned Hermes more than 24 million times. It also estimates the agent accounts for about 2.5% of global AI token usage. Those are company estimates. A clone is not necessarily an active user, a paying account or a contracted business customer. The token-share estimate has no public independent audit in the materials reviewed. For investors, the gap between distribution and revenue is central to the story.
For readers new to the category, our guide to AI agents explains why a tool-using agent differs from a chatbot. Hermes belongs in that broader class, but it is not enough to say an agent can act. A business needs to define which actions are allowed, where data goes, how outcomes are checked and who is accountable when an action fails.
The enterprise challenge behind Hermes for Businesses
Rolnick’s note promises model choice based on price and task, privacy, safe scaling and ownership of company knowledge. Those are proposed product benefits, not evidence of production deployments. Nous has not provided a public price list, dated general-availability commitment, independent security assessment or detailed customer case study in the announcement. Accordingly, the useful question is not whether the software is open source, but whether a buyer can run it within enforceable controls.
A bounded evaluation would start with one low-risk workflow, such as assembling a draft internal research note from approved documents. The buyer would restrict the agent’s tools, record every action, measure error rates and require human approval before any external communication or irreversible change. Next it would test prompt-injection resistance, confidential-data leakage and recovery after a failed tool call. These are evaluation criteria, not capabilities that Nous has proved across every environment.
Model choice also creates a trade-off. A company might select one model for cost and another for a difficult task, but quality, latency and data-handling policies can change with the choice. If a router selects models automatically, the enterprise still needs a record of which model handled each request. Finance teams need the full cost of tokens, hosting, administration and review, not just a headline inference price.
Our coverage of OpenClaw Enterprise’s control plane shows why this layer is becoming a category of its own. Similarly, Raindrop’s agent-testing funding highlights the need to turn observed failures into pre-release tests. Neither example proves anything about Hermes specifically; they describe the controls a buyer should ask Nous to demonstrate.
Why the reported valuation depends on conversion
TechCrunch and SiliconANGLE each place the financing at a reported $1.5 billion valuation. That number is meaningful as a marker of investor expectations, but private-company valuations can reflect financing terms that public summaries do not explain. Neither the company note nor the publisher reports reviewed here supplies enough detail to calculate an enterprise revenue multiple on a comparable accounting basis.
TechCrunch relays The Wall Street Journal’s reporting that Nous had about $36 million in annualised revenue by mid-September and expected to exceed $100 million before year-end. Those are reported, company-linked figures and a forward-looking expectation, respectively. Annualised revenue is a run-rate measure, not the same as audited revenue for a completed year. The $100 million figure is a target, not a result; it must not be presented as realised sales.
For an open-source company, the conversion path usually has several stages: discovery by developers, repeated team use, administrative rollout, contracted deployment and renewal. A clone count can help at the first stage, but it cannot establish the later ones. Investors and buyers will need evidence of retained paying customers, contract size, support burden and deployment economics. None of those metrics appears in the October 7 company note.
The round gives Nous resources to hire and build, but funding itself does not validate model performance, safety or demand. It also introduces execution pressure. Enterprise contracts can involve procurement, legal review, data-location requirements, service commitments and complex integrations. If the company succeeds, its open distribution could lower discovery costs. If it fails to convert that reach into trusted deployments, a large reported valuation will have been an anticipation rather than a measure of established business scale.
What the story means for Indian teams
There is no announced India-specific Hermes launch or customer contract in the sources reviewed. The relevance for Indian software exporters, startups and enterprise buyers is a decision framework. Many teams are testing agents in support, engineering and operations. A permissive licence lets them inspect a tool, but it does not answer whether a deployment can satisfy local data rules, contractual restrictions or internal security policy. Those checks remain the buyer’s responsibility.
Indian teams considering the Nous Research Hermes agent should compare a self-managed pilot with a managed commercial option on the same task set. They should record completion quality, operator intervention, security findings and total cost for each. This comparison matters more than a broad claim that an open agent is always cheaper or more private. The answer depends on the model, infrastructure, data flow and support model actually chosen.
The broader commercial signal is that capital is following AI agents that have built developer distribution. That may create opportunities for Indian systems integrators and SaaS vendors to package governance, testing and domain workflows. It does not guarantee that Hermes will win a particular sector. A buyer should ask for contractual controls and production references rather than extrapolating from a global clone estimate.
What comes next
Watch for Nous to publish concrete Hermes for Businesses documentation: availability, pricing, model-routing details, administrative controls, data retention, audit logs and independently testable security claims. Then watch for customer evidence. A named paid deployment, measured workflow quality and renewals would say more about the enterprise transition than one more usage estimate.
For now, the verified event is a $90 million financing and an announced business direction. The reported $1.5 billion valuation and company-estimated adoption figures are useful context when clearly labelled. The open question is whether Hermes can give businesses both the flexibility that made it popular and the control needed for dependable work.
Frequently asked questions
How much did Nous Research raise?
Nous Research said on October 7, 2026 that it raised $90 million. TechCrunch and SiliconANGLE described the financing as a Series B.
Did Nous Research confirm a $1.5 billion valuation?
No. TechCrunch, SiliconANGLE and The Next Web reported a $1.5 billion valuation, but the company’s fundraise note did not state a valuation.
Is Hermes for Businesses available now?
Nous announced it will build a business offering, but its fundraise note did not provide a general-availability date, full price list or independently verified customer results.
Are 24 million clones the same as 24 million customers?
No. The clone figure is the company’s own estimate of software distribution. It is not an audited count of active users, paying businesses or contracts.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.



